ECHOCARDIOGRAPHIC MOLECULAR IMAGING OF THE EFFECT OF ANTI-CYTOKINE THERAPY FOR ATHEROSCLEROSIS.

[1]  E. Latz,et al.  Platelets Fuel the Inflammasome Activation of Innate Immune Cells , 2019, bioRxiv.

[2]  P. Ridker.  Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[3]  J. Lindner,et al.  Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow , 2018, Circulation. Cardiovascular imaging.

[4]  Jong Seong Roh,et al.  Damage-Associated Molecular Patterns in Inflammatory Diseases , 2018, Immune network.

[5]  Junmei Chen,et al.  Myocardial Infarction Produces Sustained Proinflammatory Endothelial Activation in Remote Arteries. , 2018, Journal of the American College of Cardiology.

[6]  J. Lindner,et al.  Molecular Imaging in Drug Discovery and Development. , 2018, Circulation. Cardiovascular imaging.

[7]  P. Libby,et al.  Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial , 2017, The Lancet.

[8]  P. Libby,et al.  The Present and FutureReview Topic of the WeekInterleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond , 2017 .

[9]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[10]  P. Mulder,et al.  The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure , 2017, JACC. Basic to translational science.

[11]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[12]  P. Libby,et al.  Targeting Interleukin-1&bgr; Reduces Leukocyte Production After Acute Myocardial Infarction , 2015, Circulation.

[13]  A. Dart,et al.  Systemic inflammatory response following acute myocardial infarction , 2015, Journal of geriatric cardiology : JGC.

[14]  A. Chauhan,et al.  ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF‐dependent mechanism , 2014, Journal of thrombosis and haemostasis : JTH.

[15]  Sungeun Kim,et al.  Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by 18F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging , 2014, Circulation. Cardiovascular imaging.

[16]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[17]  S. Bunting,et al.  Molecular Imaging of the Initial Inflammatory Response in Atherosclerosis: Implications for Early Detection of Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[18]  J. Wagner,et al.  The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage , 2004, Cancer Immunology, Immunotherapy.

[19]  Tadashi Miyamoto,et al.  Neutralization of interleukin-1β in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling , 2001 .

[20]  D. Dixon,et al.  Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.

[21]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[22]  P. Libby,et al.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. , 1990, The Journal of clinical investigation.

[23]  R. Cotran,et al.  Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. , 1985, The American journal of pathology.